Loading clinical trials...
Loading clinical trials...
A Randomized, Double-blind, Placebo-controlled, 3 Dose Level, Parallel Group Study of the Efficacy and Safety of Plecanatide in Adolescents 12 to < 18 Years of Age With Chronic Idiopathic Constipation (CIC)
Conditions
Interventions
Plecanatide
Matching placebo
Locations
36
United States
Synergy Research Site
Foley, Alabama, United States
Synergy Research Site
Jonesboro, Arkansas, United States
Synergy Research Site
Cerritos, California, United States
Synergy Research Site
Corona, California, United States
Synergy Research Site
Downey, California, United States
Synergy Research Site
Huntington Beach, California, United States
Start Date
January 1, 2017
Primary Completion Date
September 7, 2018
Completion Date
September 7, 2018
Last Updated
October 4, 2019
NCT04838522
NCT06736912
NCT03879239
NCT02819297
NCT03097861
NCT01982240
Lead Sponsor
Bausch Health Americas, Inc.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions